According to the data monitored by the “A-share green report” project, Shanghai Labway Clinical Laboratory Co.Ltd(301060) (301060. SZ) holding subsidiary Danyang Shanghai Labway Clinical Laboratory Co.Ltd(301060) inspection laboratory Co., Ltd. Danyang Shanghai Labway Clinical Laboratory Co.Ltd(301060) inspection laboratory project environmental review approval was approved in principle. The total investment of the project is 50 million yuan. The approval information was disclosed by relevant regulatory authorities on January 12, 2022.
The “A-share green report” project is jointly launched by the daily economic news and the well-known NGO Public Environmental Research Center (IPE) in the field of environmental protection, aiming to make the environmental information of listed companies more sunny and transparent. Based on the authoritative environmental regulatory data released by 31 provinces, municipalities and 337 prefecture level municipal governments, the project selects and monitors the environmental performance of listed companies and their subsidiaries (including branches, joint-stock companies and holding companies), makes professional data analysis and in-depth interpretation, intelligently writes daily, timely publishes the AI green report of listed companies, and launches the A-share green weekly report every week, Regularly and dynamically update the environmental risk list of listed companies.
According to the A-share green weekly report of the previous period (total issue 61), a total of 63 listed companies have recently exposed environmental risks, mainly in Beijing, Zhejiang, Jiangsu and Guangdong. Among them, 25 are state-owned controlled enterprises and 11 are enterprises with a market value of 100 billion. In addition to environmental risks, in the first week of January 2022, 21 projects of A-share listed companies and their subsidiaries entered the publicity status of EIA approval.
According to the 2021 semi annual report, the main businesses of Shanghai Labway Clinical Laboratory Co.Ltd(301060) are agency revenue, diagnostic services and other businesses, accounting for 53.63%, 46.15% and 0.22% of revenue respectively.
(reporter Liang Xiao)
